(Q79446833)
Statements
The contribution of pharmacokinetic-pharmacodynamic modelling with Monte Carlo simulation to the development of susceptibility breakpoints for Neisseria meningitidis (English)
Burgess DS
Frei CR
Lewis Ii JS
Fiebelkorn KR